Dr. Robert Jenq is an Assistant Professor of the Department of Genomic Medicine and Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, Houston, TX. His aim is to develop and evaluate strategies that improve outcomes after hematopoietic stem cell transplantation (HSCT), in particular by augmenting graft-versus-tumor (GVT) to reduce the rates of malignant relapse and alleviating graft-versus-host disease (GVHD).
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)